Needham upgraded shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) from Hold to Buy, with a price target of $155. The price target, according to the firm, is based on 25 times its estimated earnings per share for 2022, discounted 20 percent annually.
Analysts Alan Carr and Danielle. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to:
Shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) were trading higher by nearly 9 percent early Monday morning. Acadia Pharmaceuticals announced after Friday s market close that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration will review data. Read More. Don t Miss Any Updates! News Directly in Your Inbox Subscribe to: